share_log

Inspire Medical Systems, Inc.'s (NYSE:INSP) Profit Outlook

Inspire Medical Systems, Inc.'s (NYSE:INSP) Profit Outlook

Inspire 医疗系统有限公司”s(纽约证券交易所代码:INSP)利润展望
Simply Wall St ·  05/08 13:50

With the business potentially at an important milestone, we thought we'd take a closer look at Inspire Medical Systems, Inc.'s (NYSE:INSP) future prospects. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The US$7.4b market-cap company announced a latest loss of US$21m on 31 December 2023 for its most recent financial year result. The most pressing concern for investors is Inspire Medical Systems' path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

由于该业务可能处于重要的里程碑,我们认为应该仔细研究Inspire Medical Systems, Inc.'s(纽约证券交易所代码:INSP)的未来前景。Inspire Medical Systems, Inc. 是一家医疗技术公司,专注于为美国和国际上的阻塞性睡眠呼吸暂停(OSA)患者开发和商业化微创解决方案。这家市值为74亿美元的公司于2023年12月31日宣布其最新财年业绩亏损2100万美元。投资者最紧迫的担忧是Inspire Medical Systems的盈利之路——它何时会实现盈亏平衡?我们简要概述了行业分析师对该公司、盈亏平衡年份和隐含增长率的预期。

According to the 17 industry analysts covering Inspire Medical Systems, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$24m in 2025. The company is therefore projected to breakeven just over a year from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 52% is expected, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

根据报道Inspire Medical Systems的17位行业分析师的说法,人们的共识是盈亏平衡已临近。他们预计,该公司将在2024年蒙受最终亏损,然后在2025年产生2400万美元的正利润。因此,预计该公司将在一年多后实现盈亏平衡。为了达到这个盈亏平衡日期,我们计算了公司必须同比增长的速度。事实证明,预计年均增长率为52%,这表明分析师充满信心。如果事实证明这个利率过于激进,该公司的盈利时间可能比分析师预测的要晚得多。

earnings-per-share-growth
NYSE:INSP Earnings Per Share Growth May 8th 2024
纽约证券交易所:INSP 每股收益增长 2024 年 5 月 8 日

Given this is a high-level overview, we won't go into details of Inspire Medical Systems' upcoming projects, though, bear in mind that generally a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

鉴于这是一个高层次的概述,我们不会详细介绍Inspire Medical Systems即将推出的项目,但请记住,总体而言,高增长率并非不寻常,尤其是在公司处于投资期时。

One thing we'd like to point out is that Inspire Medical Systems has no debt on its balance sheet, which is rare for a loss-making growth company, which typically has high debt relative to its equity. The company currently operates purely off its shareholder funding and has no debt obligation, reducing concerns around repayments and making it a less risky investment.

我们想指出的一件事是,Inspire Medical Systems的资产负债表上没有债务,这对于亏损的成长型公司来说是罕见的,因为相对于股权而言,债务通常很高。该公司目前完全靠股东资金运营,没有债务义务,这减少了对还款的担忧,使其成为一项风险较小的投资。

Next Steps:

后续步骤:

There are too many aspects of Inspire Medical Systems to cover in one brief article, but the key fundamentals for the company can all be found in one place – Inspire Medical Systems' company page on Simply Wall St. We've also compiled a list of pertinent aspects you should look at:

Inspire Medical Systems的很多方面都无法在一篇简短的文章中介绍,但该公司的关键基础知识都可以在一个地方找到——Inspire Medical Systems的公司页面Simply Wall St. 我们还整理了一份你应该考虑的相关方面清单:

  1. Valuation: What is Inspire Medical Systems worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Inspire Medical Systems is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Inspire Medical Systems's board and the CEO's background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
  1. 估值:Inspire 医疗系统今天的价值是多少?价格中是否已经考虑了未来的增长潜力?我们的免费研究报告中的内在价值信息图有助于可视化Inspire Medical Systems目前是否被市场错误定价。
  2. 管理团队:一支经验丰富的管理团队掌舵增强了我们对业务的信心——看看谁是Inspire Medical Systems董事会成员以及首席执行官的背景。
  3. 其他表现优异的股票:还有其他股票可以提供更好的前景并有良好的往绩记录吗?在这里浏览我们免费列出的这些优质股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发